Blood pressure improvement may happen as part of a broader metabolic shift
See how science, strategy, and innovation are transforming the GLP-1 space: #GLP1 #oralGLP1 #metabolichealth #diabetescare #obesity #obesitytreatment #pharmainnovation #futureproofingbusinesses #IeB To view or add a comment, sign in #MIMSPharmaMarketInsightUpdate, September 2025 Including: SGLT2 inhibitors should be offered first-line to people with heart failure with reduced ejection fraction A new formulation of Rybelsus (semaglutide) tablets has been released The first inhaled levodopa product, Inbrija (levodopa), has been launched
Shubham Suggests
Impact Of Prolonged Fasting On Insulin Secretion, Insulin Action, And Hepatic Versus Whole Body Insulin Secretion Disposition Indices In Healthy Young Males
"With tens of millions of people already using GLP-1 drugs, the reductions in deaths, overdoses, hospitalizations and new diagnoses could translate into thousands of prevented serious events each year," Dr
This is because no drug manufacturer currently produces methylene blue capsules commercially